Early-Life Antibiotics and Childhood Obesity: Yeast Probiotics as a Strategy to Modulate Gut Microbiota

This study aimed to review the existing literature to investigate the potential link between early-life antibiotic use and being overweight or obese in children. PubMed, Web of Science, Embase, Google Scholar, and Cochrane Library were searched to identify studies published until August 2021 that as...

Descripción completa

Detalles Bibliográficos
Autores principales: Rawat, Sanjiv Singh, Narain, Nigam P, Marathe, Sanjay M, Sonawale, Sourabh B, Veligandla, Krishna C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134683/
https://www.ncbi.nlm.nih.gov/pubmed/37123776
http://dx.doi.org/10.7759/cureus.36795
_version_ 1785031811738370048
author Rawat, Sanjiv Singh
Narain, Nigam P
Marathe, Sanjay M
Sonawale, Sourabh B
Veligandla, Krishna C
author_facet Rawat, Sanjiv Singh
Narain, Nigam P
Marathe, Sanjay M
Sonawale, Sourabh B
Veligandla, Krishna C
author_sort Rawat, Sanjiv Singh
collection PubMed
description This study aimed to review the existing literature to investigate the potential link between early-life antibiotic use and being overweight or obese in children. PubMed, Web of Science, Embase, Google Scholar, and Cochrane Library were searched to identify studies published until August 2021 that assessed the relationship between early-childhood antibiotic use and measures of body mass index. The studies included children aged 0-18 years. Only cohort studies were taken into consideration. Studies published in languages other than English were excluded. Antibiotic usage in early life may increase the risk of obesity in children and the addition of yeast probiotics, such as Saccharomyces boulardii CNCM I 745, to antibiotic prescription can serve as a potential option to mitigate this risk.
format Online
Article
Text
id pubmed-10134683
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-101346832023-04-28 Early-Life Antibiotics and Childhood Obesity: Yeast Probiotics as a Strategy to Modulate Gut Microbiota Rawat, Sanjiv Singh Narain, Nigam P Marathe, Sanjay M Sonawale, Sourabh B Veligandla, Krishna C Cureus Pediatrics This study aimed to review the existing literature to investigate the potential link between early-life antibiotic use and being overweight or obese in children. PubMed, Web of Science, Embase, Google Scholar, and Cochrane Library were searched to identify studies published until August 2021 that assessed the relationship between early-childhood antibiotic use and measures of body mass index. The studies included children aged 0-18 years. Only cohort studies were taken into consideration. Studies published in languages other than English were excluded. Antibiotic usage in early life may increase the risk of obesity in children and the addition of yeast probiotics, such as Saccharomyces boulardii CNCM I 745, to antibiotic prescription can serve as a potential option to mitigate this risk. Cureus 2023-03-28 /pmc/articles/PMC10134683/ /pubmed/37123776 http://dx.doi.org/10.7759/cureus.36795 Text en Copyright © 2023, Rawat et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Pediatrics
Rawat, Sanjiv Singh
Narain, Nigam P
Marathe, Sanjay M
Sonawale, Sourabh B
Veligandla, Krishna C
Early-Life Antibiotics and Childhood Obesity: Yeast Probiotics as a Strategy to Modulate Gut Microbiota
title Early-Life Antibiotics and Childhood Obesity: Yeast Probiotics as a Strategy to Modulate Gut Microbiota
title_full Early-Life Antibiotics and Childhood Obesity: Yeast Probiotics as a Strategy to Modulate Gut Microbiota
title_fullStr Early-Life Antibiotics and Childhood Obesity: Yeast Probiotics as a Strategy to Modulate Gut Microbiota
title_full_unstemmed Early-Life Antibiotics and Childhood Obesity: Yeast Probiotics as a Strategy to Modulate Gut Microbiota
title_short Early-Life Antibiotics and Childhood Obesity: Yeast Probiotics as a Strategy to Modulate Gut Microbiota
title_sort early-life antibiotics and childhood obesity: yeast probiotics as a strategy to modulate gut microbiota
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134683/
https://www.ncbi.nlm.nih.gov/pubmed/37123776
http://dx.doi.org/10.7759/cureus.36795
work_keys_str_mv AT rawatsanjivsingh earlylifeantibioticsandchildhoodobesityyeastprobioticsasastrategytomodulategutmicrobiota
AT narainnigamp earlylifeantibioticsandchildhoodobesityyeastprobioticsasastrategytomodulategutmicrobiota
AT marathesanjaym earlylifeantibioticsandchildhoodobesityyeastprobioticsasastrategytomodulategutmicrobiota
AT sonawalesourabhb earlylifeantibioticsandchildhoodobesityyeastprobioticsasastrategytomodulategutmicrobiota
AT veligandlakrishnac earlylifeantibioticsandchildhoodobesityyeastprobioticsasastrategytomodulategutmicrobiota

Ejemplares similares